Evidence for platelet-activating factor receptor subtypes on human polymorphonuclear leukocyte membranes

Biochemical Pharmacology

Volumn 54, Issue 9, 1997, Pages 1007-1012

  LeVan, Tricia D ^a,b   Dow, Sean B ^a   Chase, Peter B ^b   Bloom, John W ^a,b   Regan, John W ^b   Cunningham, Eve ^a   Halonen, Marilyn ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

G protein coupled receptor; Platelet activating factor; Polymorphonuclear leukocytes; Radioligand binding

Indexed keywords

CELL SURFACE RECEPTOR; RECEPTOR SUBTYPE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; RADIOASSAY; SCINTILLATION;

ANIMALS; AZEPINES; COS CELLS; HUMANS; NEUTROPHILS; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; TRIAZOLES;

EID: 0030659006     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00249-9     Document Type: Article

References (22)

1. Snyder F, Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 259: C697-C708, 1990.
2. Venable ME, Zimmerman GA, McIntyre TM and Prescott SM, Platelet-activating factor: A phospholipid autacoid with diverse actions. J Lipid Res 34: 691-702, 1993.
3. Honda Z, Nakamura M, Miki I, Minami M, Watanabe T, Seyama Y, Okado H, Toh H, Ito K, Miyamoto T and Shimizu T, Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349: 342-346, 1991.
4. Seyfried CE, Schweickart VL, Godiska R and Gray PW, The human platelet-activating factor receptor gene (PTAFR) contains no introns and maps to chromosome 1. Genomics 13: 832-834, 1992.
5. Chase PB, Halonen M and Regan JW, Cloning of a human platelet-activating factor receptor gene: Evidence for an intron in the 5′-untranslated region. Am J Respir Cell Mol Biol 8: 240-244, 1993.
6. Ye RD, Prossnitz ER, Zou A and Cochrane C, Characteriza-tion of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun 180: 105-111, 1991.
7. Naccache PH, Molski MM, Volpi M, Becker EL and Sha'afi RI, Unique inhibitory profile of platelet activating factor induced calcium mobilization, polyphosphoinositide turnover and granule enzyme secretion in rabbit neutrophils towards pertussis toxin and phorbol ester. Biochem Biophys Res Com-mun 130: 677-684, 1985.
8. Pinckard RN, Showell HJ, Castillo R, Lear C, Breslow R, McManus LM, Woodard DS and Ludwig JC, Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activat-ing factor. J Immunol 148: 3528-3535, 1992.
9. Hwang SB, Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem 263: 3225-3233, 1988.
10. O'Flaherty JT, Surles JR, Redman J, Jacobson D, Piantadosi C and Wykle RL, Binding and metabolism of platelet-activating factor by human neutrophils. J Clin Invest 78: 381-388, 1986.
11. 3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes. J Lipid Mediat 7: 57-78, 1993.
12. Ludwig JD, Hoppens C, McManus LM, Mott GE and Pinckard RN, Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): Role of extracellular albumin. Arch Biochem Biophys 241: 237-247, 1985.
13. Gomez J, Bloom JW, Yamamura HI and Halonen M, Characterization of receptors for platelet-activating factor in guinea pig lung membranes. Am J Respir Cell Mol Biol 3: 259-264, 1990.
14. Unnerstall JR, Computer-assisted analysis of binding data. In: Methods in Neurotransmitter Receptor Analysis (Ed. Yamamura HI), pp. 37-68. Raven Press, New York, 1990.
15. i) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108, 1973.
16. Bylund DB and Yamamura HI, Methods for receptor binding. In: Methods in Neurotransmitter Receptor Analysis (Ed. Yamamura HI), pp. 1-35. Raven Press, New York, 1990.
17. Kroegel C, Warner JA, Giembycz MA, Matthys H, Lichtenstein LM and Barnes PJ, Dual transmembrane signalling mechanisms in eosinophils: Evidence for two functionally distinct receptors for platelet-activating factor. Int Arch Allergy Immunol 99: 226-229, 1992.
18. Kroegel C, Yukawa T, Westwick J and Barnes PJ, Evidence for two platelet activating factor receptors, on eosinophils: Dissociation between PAF-induced intracellular calcium mobilization degranulation and Superoxides anion generation in eosinophils. Biochem Biophys Res Commun 162: 511-521, 1989.
19. 3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes. Biochem Pharmocol 45: 51-58, 1993.
20. Valone FH, Coles E, Reinhold VR and Goetzl EJ, Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol 129: 1637-1641, 1982.
21. Lambrecht G and Parnham MJ, Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes. Br J Pharmacol 87: 287-289, 1986.
22. Plassat J-L, Beschert U, Amlaiky N and Hen R, The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family. EMBO J 11: 4779-4786, 1992.